propranolol has been researched along with Heart Disease, Ischemic in 124 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 7.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| "The effects of ivabradine, a novel heart rate-reducing agent that inhibits the cardiac pacemaker current If, were compared with those of the beta-adrenergic blocker propranolol, in a model of exercise-induced regional myocardial ischemia in pigs." | 7.72 | Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. ( Bidouard, JP; Lesage, L; Péglion, JL; Reure, H; Vilaine, JP, 2003) |
| " The purpose of this study was to examine whether zatebradine is effective against ischemia and reperfusion-induced arrhythmias in dogs compared to propranolol." | 7.70 | Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias. ( Chino, D; Furukawa, Y; Hashimoto, K; Naito, H; Yamada, C, 2000) |
| ") administration of (+/-) propranolol (100-200-300 microg/animal/day, during 7 days) or (+/-) verapamil (40-80-160 microg/animal/day, during 7 days) afforded a significant protection (with the exception of the lowest dose) on the investigated parameters: arrhythmias, ischemic zone (in coronary ligated rats), lactate dehydrogenase and aspartate aminotransferase activity of the serum, focal necrosis (in isoproterenol treated rats)." | 7.70 | The influence of intracerebroventricular administration of (+/-) propranolol and (+/-) verapamil on experimental myocardial ischemia and necrosis in rats. ( Blidaru, M; Cuparencu, B; Pleşca-Manea, L, 2000) |
| "The trial included 147 men with ischemic heart disease, stable angina pectoris (functional class II-III)." | 6.70 | [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris]. ( Bochkareva, EV; Butina, EK; Dmitrieva, NA; Kokurina, EV, 2002) |
| "Pretreatment with propranolol prevents damage." | 5.31 | [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. ( Cerro Sánchez, J; Domínguez Roldán, JM; Hernández Fernández, A; Ojeda Rivero, R; Ordóñez Fernández, A, 2002) |
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 5.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "The effects of verapamil, nifedipine, propranolol, and combinations of nifedipine+propranolol and nifedipine+verapamil were studied in 60 patients with stable angina pectoris." | 5.07 | [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris]. ( Lysenko, AF; Voronkov, LG, 1992) |
| "In acute experiments in anesthetized rabbits the changes of the pulmonary hemodynamics following 60 s myocardial ischemia in the region of the descendent left coronary artery were studied in control animals and after the blockade of α-adrenoreceptors by phentolamine or β-adrenoreceptors by propranolol." | 3.81 | [Pulmonary hemodynamics following experimental myocardial ischemia after the blockade of adrenergic receptors]. ( Evlakhov, VI; Poiasov, IZ, 2015) |
| " The ACR, LS, and CS were compared with those by sonomicrometry at baseline and during pharmacological stress tests (dobutamine and propranolol infusion) and acute myocardial ischemia induced by occlusion of mid-left ascending artery." | 3.77 | Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging. ( Aonuma, K; Enomoto, Y; Ishizu, T; Seo, Y; Sugimori, H, 2011) |
| "In order to explore the scientific connotation of "Fangzhengduiying (formula corresponding to pattern types)", "Qiyinliangxuzheng (Qi and Yin deficiency pattern)" of myocardial ischemia rat model and GC-TOF/MS based metabonomic method were used for comparing the effects of Sheng-mai injection, Salvia injection and propranolol in the present study." | 3.77 | [Metabonomic phenotype of "formula corresponding to pattern types" based on "qi and yin deficiency pattern" of myocardial ischemia rat model]. ( A, JY; Gu, SH; Hao, HP; Liu, LS; Wang, GJ; Yan, B; Zha, WB; Zhang, Y, 2011) |
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 3.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| " Segmental longitudinal (LS), radial (RS), and circumferential strain (CS) measurements by 3D-STI were compared with those by sonomicrometry at baseline and during pharmacological stress tests (dobutamine and propranolol infusion) and acute myocardial ischemia induced by coronary artery occlusion." | 3.75 | Validation of 3-dimensional speckle tracking imaging to quantify regional myocardial deformation. ( Aonuma, K; Enomoto, Y; Ishizu, T; Kawamura, R; Machino, T; Seo, Y; Sugimori, H; Yamamoto, M, 2009) |
| " The elevated ST segments of electrocardiogram (ECG), cardiac arrhythmias, and ratio of infarct size/risk zone were compared among the normal control (NC), ischemia and reperfusion (IR), electro-acupuncture (EA), electro-acupuncture plus propranolol (EAP), and EA at nonacupoint (EAN) groups." | 3.73 | A preliminary study on the cardioprotection of acupuncture pretreatment in rats with ischemia and reperfusion: involvement of cardiac beta-adrenoceptors. ( Fu, W; Gao, J; Jin, Z; Yu, X, 2006) |
| "The effects of ivabradine, a novel heart rate-reducing agent that inhibits the cardiac pacemaker current If, were compared with those of the beta-adrenergic blocker propranolol, in a model of exercise-induced regional myocardial ischemia in pigs." | 3.72 | Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. ( Bidouard, JP; Lesage, L; Péglion, JL; Reure, H; Vilaine, JP, 2003) |
| "To assess the strategy of titration for prescribing an efficient dosage of propranolol to reduce myocardial ischemia in the elderly." | 3.72 | Strategy for identifying an efficient dosage of beta-blocker for elderly patients with myocardial ischemia and preserved left ventricular function. ( Abe, R; Dal Bó, C; de Oliveira, MA; Gebara, O; Giorgi, MC; Meneghetti, JC; Nussbacher, A; Pierri, H; Serro-Azul, JB; Wajngarten, M, 2004) |
| " However, after testing, upon injection of propranolol, the patient suffered chest pain associated with ST elevation and severe regional systolic abnormalities." | 3.71 | [Coronary Spasm after Administration of Propranolol during Dobutamine Stress Echocardiography]. ( Almeria, C; Alvarez, L; Mataix, L; Moreno, R; Rodrigo, JL; Zamorano, J, 2002) |
| "To assess the efficacy of long-acting propranolol in elderly patients with essential hypertension (EH) and coronary disease (CD)." | 3.70 | [Betacap efficiency in elderly patients with coronary heart disease and essential hypertension]. ( Bisengalieva, GK; Goncharov, LF; Zaslavskaia, RM; Zholdin, BK, 1998) |
| "Carvedilol, a selective alpha1 and non-selective beta-adrenoceptor antagonist and antioxidant, has been shown to provide significant cardiac protection in animal models of myocardial ischemia." | 3.70 | Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. ( Arch, JR; Cheng, HY; Feuerstein, G; Hieble, JP; Liu, GL; Ma, XL; Ruffolo, RR; Yue, TL, 1998) |
| "The metabolic effects during myocardial ischemia and sustained reperfusion of the antianginal agents diltiazem (n = 10) and propranolol (n = 10) were monitored with noninvasive phosphorus nuclear magnetic resonance spectroscopy to establish any correlation between metabolic changes and infarct size." | 3.70 | Noninvasive assessment of pharmaceutical intervention during myocardial ischemia-reperfusion in a canine model using two-dimensional 31P chemical shift imaging. ( Campbell, CM; Sykes, J; Thompson, RT; Wisenberg, G, 1998) |
| ") reduced or completely abolished the ventricular fibrillation (VF) induced by reperfusion after 5 min of regional ischemia, while lidocaine, a class I antiarrhythmic agent, showed less effect against VF as compared with FR168888." | 3.70 | Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other cardioprotective compounds. ( Goto, T; Maeda, K; Ohara, F; Ohkubo, K; Ozaki, T; Seki, J; Sugimoto, T; Yamamoto, N, 1999) |
| " The purpose of this study was to examine whether zatebradine is effective against ischemia and reperfusion-induced arrhythmias in dogs compared to propranolol." | 3.70 | Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias. ( Chino, D; Furukawa, Y; Hashimoto, K; Naito, H; Yamada, C, 2000) |
| ") administration of (+/-) propranolol (100-200-300 microg/animal/day, during 7 days) or (+/-) verapamil (40-80-160 microg/animal/day, during 7 days) afforded a significant protection (with the exception of the lowest dose) on the investigated parameters: arrhythmias, ischemic zone (in coronary ligated rats), lactate dehydrogenase and aspartate aminotransferase activity of the serum, focal necrosis (in isoproterenol treated rats)." | 3.70 | The influence of intracerebroventricular administration of (+/-) propranolol and (+/-) verapamil on experimental myocardial ischemia and necrosis in rats. ( Blidaru, M; Cuparencu, B; Pleşca-Manea, L, 2000) |
| "Propranolol and lidocaine are effective antiarrhythmic drugs in myocardial ischemia and infarction." | 3.68 | Propranolol and lidocaine inhibit neural norepinephrine release in hearts with increased extracellular potassium and ischemia. ( Dart, AM; Du, XJ; Fox, KA; Riemersma, RA, 1993) |
| " Acute regional myocardial ischemia (MI) was induced by left coronary artery branch occlusion and quantitated from epicardial NADH-fluorescence photography." | 3.68 | Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts. ( Klaus, W; Rösen, R; Rump, AF, 1993) |
| "The trial included 147 men with ischemic heart disease, stable angina pectoris (functional class II-III)." | 2.70 | [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris]. ( Bochkareva, EV; Butina, EK; Dmitrieva, NA; Kokurina, EV, 2002) |
| " In acutely dosed rats, where protein synthesis is reduced, protein carbonyl concentrations (an index of oxidative damage to muscle) also decline slightly or are unaltered, contrary to the expected increase." | 2.40 | Oxidants, antioxidants and alcohol: implications for skeletal and cardiac muscle. ( Falkous, G; Mantle, D; Patel, VB; Preedy, VR; Reilly, ME; Richardson, PJ, 1999) |
| "Propranolol was given 1 h or daily for 3 months, whole-cell patch-clamp techniques were used to measure I(to)." | 1.36 | Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia. ( Cao, YX; Hong, Y; Liu, Y; Lu, YJ; Shan, HL; Xu, CQ; Yang, BF; Zhang, JL; Zhang, L; Zhao, M, 2010) |
| "Carvedilol is a beta-adrenoceptor blocker with a vasodilatory action that is more effective for the treatment of congestive heart failure than other beta-blockers." | 1.32 | Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "The severity of arrhythmias (arrhythmia score, AS) was also markedly attenuated by both interventions (IPC: AS 1." | 1.31 | Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels. ( Pancza, D; Ravingerová, T; Styk, J; Ziegelhoffer, A, 2002) |
| "Pretreatment with propranolol prevents damage." | 1.31 | [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. ( Cerro Sánchez, J; Domínguez Roldán, JM; Hernández Fernández, A; Ojeda Rivero, R; Ordóñez Fernández, A, 2002) |
| "In experiments involving simulation of ischemic heart disease in adult rabbits, morphofunctional aspects were studied of cardioprotective action of propranolol on the contractile myocardium." | 1.31 | [Morphofunctional aspects of cardioprotective effect of propranolol in modelling of chronic ischemic heart disease]. ( Danilishina, MV; Gavrish, AS; Shchul'ts, NV; Verbitskiĭ, VV, 2002) |
| "Results indicate that T4-induced cardiac hypertrophy enhances postischemic cardiac dysfunction." | 1.31 | Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. ( Asahi, T; Oshiro, Y; Shimabukuro, M; Takasu, N; Yoshida, H, 2001) |
| "Pre-treatment with propranolol at the concentrations of 10 to 100 microM for the final 3 min of pre-ischaemia resulted in the improvement of ischaemia/reperfusion-induced contractile dysfunction, release of creatine kinase (CK) into perfusate, and decrease in myocardial high-energy phosphates." | 1.31 | Protective effect of propranolol on mitochondrial function in the ischaemic heart. ( Inoue, R; Iwai, T; Kasahara, S; Takeo, S; Tanonaka, K, 2002) |
| "40 patients with ischemic heart disease and angina of effort (class II-III) exposed to laser therapy each 6 months for 2 years entered the study." | 1.30 | [The dynamics of blood lipid composition in patients with ischemic heart disease in the process of multiple laser therapy combined with anaprilin and verapamil administration]. ( Mironova, NA; Senatorov, IuN; Strel'tsova, NN; Vasil'ev, AP, 1997) |
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 1.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "In many species arrhythmias induced by myocardial ischaemia appear to be in part dependent upon cardiac sympathetic nerves." | 1.30 | Cardiac transplantation does not effect ischaemia-induced arrhythmias in rats. ( Guo, P; Pugsley, MK; Walker, MJ; Yong, SL, 1999) |
| " A combination of obsidan and trental, 300-400 mg/day, eliminated adverse effects in the microcirculatory bed in the absence of an excessive drop in blood pressure." | 1.29 | [Adverse effects in the microcirculatory bed during obsidan treatment of patients with ischemic heart disease and possibilities of their correction by trental]. ( Kazlovskiĭ, VI, 1993) |
| "Prazosin and yohimbine were found to produce a significant increase in plasma norepinephrine levels in contrast to bunazosin, which had no significant effect." | 1.29 | Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade. ( Kono, M; Morita, S; Rubsamen, R, 1995) |
| "Only in CHD patients with ventricular tachycardia the treatment shifted the vegetative tone in the direction of parasympathetic nervous system." | 1.29 | [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy]. ( Afonskaia, NI; Belogubets, VI; Polevaia, TIu; Smetnev, AS, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.81) | 18.7374 |
| 1990's | 72 (58.06) | 18.2507 |
| 2000's | 34 (27.42) | 29.6817 |
| 2010's | 17 (13.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, I | 1 |
| Gettes, LS | 1 |
| Pearson, JT | 1 |
| Collie, N | 1 |
| Lamberts, RR | 1 |
| Inagaki, T | 1 |
| Yoshimoto, M | 1 |
| Umetani, K | 1 |
| Davis, P | 1 |
| Wilkins, G | 1 |
| Jones, PP | 1 |
| Shirai, M | 1 |
| Schwenke, DO | 1 |
| Rorabaugh, BR | 1 |
| Bui, AD | 1 |
| Seeley, SL | 1 |
| Eisenmann, ED | 1 |
| Rose, RM | 1 |
| Johnson, BL | 1 |
| Huntley, MR | 1 |
| Heikkila, ME | 1 |
| Zoladz, PR | 1 |
| Sawada, T | 1 |
| Kitagawa, H | 1 |
| Nosaka, S | 1 |
| Evlakhov, VI | 3 |
| Poiasov, IZ | 2 |
| Penson, PE | 1 |
| Ford, WR | 1 |
| Kidd, EJ | 1 |
| Broadley, KJ | 1 |
| Lu, Y | 1 |
| Zhang, Y | 2 |
| Shan, H | 1 |
| Pan, Z | 1 |
| Li, X | 1 |
| Li, B | 1 |
| Xu, C | 1 |
| Zhang, B | 1 |
| Zhang, F | 1 |
| Dong, D | 1 |
| Song, W | 1 |
| Qiao, G | 1 |
| Yang, B | 1 |
| Seo, Y | 2 |
| Ishizu, T | 2 |
| Enomoto, Y | 2 |
| Sugimori, H | 2 |
| Yamamoto, M | 1 |
| Machino, T | 1 |
| Kawamura, R | 1 |
| Aonuma, K | 2 |
| Zhang, L | 1 |
| Xu, CQ | 1 |
| Hong, Y | 1 |
| Zhang, JL | 1 |
| Liu, Y | 1 |
| Zhao, M | 1 |
| Cao, YX | 1 |
| Lu, YJ | 1 |
| Yang, BF | 1 |
| Shan, HL | 1 |
| Unuma, K | 1 |
| Shintani-Ishida, K | 1 |
| Yahagi, N | 1 |
| Tsushima, K | 1 |
| Shimosawa, T | 1 |
| Ueyama, T | 1 |
| Yoshida, K | 1 |
| Hayashi, H | 1 |
| McMurray, JJ | 1 |
| Beets, MT | 1 |
| Forringer, E | 1 |
| Fedorets, VN | 3 |
| Yan, B | 1 |
| A, JY | 1 |
| Hao, HP | 1 |
| Wang, GJ | 1 |
| Liu, LS | 1 |
| Zha, WB | 1 |
| Gu, SH | 1 |
| Long, J | 1 |
| Gao, M | 1 |
| Kong, Y | 1 |
| Shen, X | 1 |
| Du, X | 1 |
| Son, YO | 1 |
| Shi, X | 1 |
| Liu, J | 1 |
| Mo, X | 1 |
| Poyassov, IZ | 1 |
| Vaillant, F | 1 |
| Dehina, L | 1 |
| Dizerens, N | 1 |
| Bui-Xuan, B | 2 |
| Tabib, A | 1 |
| Lauzier, B | 1 |
| Chevalier, P | 1 |
| Descotes, J | 1 |
| Timour, Q | 2 |
| Ravingerová, T | 1 |
| Pancza, D | 1 |
| Ziegelhoffer, A | 1 |
| Styk, J | 1 |
| Kupriyanov, VV | 1 |
| Xiang, B | 1 |
| Sun, J | 1 |
| Jilkina, O | 1 |
| Alvarez, L | 1 |
| Zamorano, J | 1 |
| Mataix, L | 1 |
| Almeria, C | 1 |
| Moreno, R | 1 |
| Rodrigo, JL | 1 |
| Ojeda Rivero, R | 1 |
| Cerro Sánchez, J | 1 |
| Ordóñez Fernández, A | 1 |
| Domínguez Roldán, JM | 1 |
| Hernández Fernández, A | 1 |
| Butina, EK | 1 |
| Kokurina, EV | 1 |
| Dmitrieva, NA | 1 |
| Bochkareva, EV | 1 |
| Vasil'ev, AP | 4 |
| Strel'tsova, NN | 4 |
| Gorbunova, TIu | 3 |
| Catelli, M | 1 |
| Feldman, J | 1 |
| Bousquet, P | 1 |
| Tibirica, E | 1 |
| Pantos, C | 1 |
| Mourouzis, I | 1 |
| Tzeis, S | 1 |
| Moraitis, P | 1 |
| Malliopoulou, V | 2 |
| Cokkinos, DD | 2 |
| Carageorgiou, H | 1 |
| Varonos, D | 1 |
| Cokkinos, D | 1 |
| Gavrish, AS | 1 |
| Verbitskiĭ, VV | 1 |
| Shchul'ts, NV | 1 |
| Danilishina, MV | 1 |
| Skoromets, AA | 2 |
| Radchenko, VG | 2 |
| Vilaine, JP | 1 |
| Bidouard, JP | 1 |
| Lesage, L | 1 |
| Reure, H | 1 |
| Péglion, JL | 1 |
| Asanuma, H | 1 |
| Minamino, T | 2 |
| Sanada, S | 1 |
| Takashima, S | 1 |
| Ogita, H | 1 |
| Ogai, A | 1 |
| Asakura, M | 1 |
| Liao, Y | 1 |
| Asano, Y | 1 |
| Shintani, Y | 1 |
| Kim, J | 1 |
| Shinozaki, Y | 2 |
| Mori, H | 4 |
| Node, K | 2 |
| Kitamura, S | 1 |
| Tomoike, H | 1 |
| Hori, M | 2 |
| Kitakaze, M | 2 |
| Serro-Azul, JB | 1 |
| Wajngarten, M | 1 |
| Nussbacher, A | 1 |
| Giorgi, MC | 1 |
| Meneghetti, JC | 1 |
| de Oliveira, MA | 1 |
| Abe, R | 1 |
| Dal Bó, C | 1 |
| Pierri, H | 1 |
| Gebara, O | 1 |
| Huang, L | 1 |
| Weil, MH | 1 |
| Cammarata, G | 1 |
| Sun, S | 1 |
| Tang, W | 1 |
| Suematsu, Y | 1 |
| Anttila, V | 1 |
| Takamoto, S | 1 |
| del Nido, P | 1 |
| Gao, J | 1 |
| Fu, W | 1 |
| Jin, Z | 1 |
| Yu, X | 1 |
| Igarashi, N | 1 |
| Nozawa, T | 1 |
| Fujii, N | 1 |
| Suzuki, T | 1 |
| Matsuki, A | 1 |
| Nakadate, T | 1 |
| Igawa, A | 1 |
| Inoue, H | 1 |
| Bhatt, LK | 1 |
| Nandakumar, K | 1 |
| Bodhankar, SL | 1 |
| Bansal, J | 1 |
| Piplani, P | 1 |
| Mizuyama, K | 1 |
| Sato, S | 1 |
| Okubo, N | 1 |
| Naito, H | 2 |
| Ferrara, N | 1 |
| Coltorti, F | 1 |
| Leosco, D | 1 |
| Sederino, S | 1 |
| Abete, P | 1 |
| Caccese, P | 1 |
| Landing, P | 1 |
| Longobardi, G | 1 |
| Verde, R | 1 |
| Rengo, F | 2 |
| Birkeland, S | 2 |
| Westby, J | 1 |
| Hexeberg, E | 2 |
| Stramba-Badiale, M | 1 |
| Lazzarotti, M | 1 |
| Facchini, M | 1 |
| Schwartz, PJ | 4 |
| Mazur, NA | 1 |
| Pavlova, TS | 1 |
| Vasil'eva, NN | 1 |
| Kul'ginskaia, IV | 1 |
| Belogubets, VI | 1 |
| Polevaia, TIu | 1 |
| Afonskaia, NI | 1 |
| Smetnev, AS | 1 |
| Zhang, Z | 1 |
| Gao, RB | 1 |
| Xu, YQ | 1 |
| Wang, ZR | 1 |
| Xu, JM | 1 |
| Asimakis, GK | 1 |
| Conti, VR | 1 |
| Mazzù, A | 1 |
| Di Tano, G | 1 |
| Cogode, R | 1 |
| Lo Presti, G | 1 |
| Kosaka, H | 1 |
| Komamura, K | 1 |
| Tada, M | 1 |
| Inoue, M | 1 |
| Kamada, T | 1 |
| Tanabe, T | 4 |
| Takahashi, K | 2 |
| Usui, K | 3 |
| Kitada, M | 2 |
| Aronow, WS | 1 |
| Ahn, C | 1 |
| Mercando, AD | 1 |
| Epstein, S | 1 |
| V'iuchnova, ES | 2 |
| Maev, IV | 2 |
| Merzlikin, LA | 1 |
| Rynning, SE | 1 |
| Brunvand, H | 1 |
| Grong, K | 1 |
| Yoshioka, K | 1 |
| Handa, S | 3 |
| Rump, AF | 2 |
| Rösen, R | 2 |
| Klaus, W | 2 |
| Vanoli, E | 2 |
| Hull, SS | 2 |
| Foreman, RD | 2 |
| Ferrari, A | 1 |
| Hayase, N | 1 |
| Chiba, K | 1 |
| Abiko, Y | 4 |
| Ichihara, K | 2 |
| Stugaard, M | 1 |
| Risöe, C | 1 |
| Ihlen, H | 1 |
| Smiseth, OA | 1 |
| Ditchey, RV | 1 |
| Rubio-Perez, A | 1 |
| Slinker, BK | 1 |
| Kazlovskiĭ, VI | 1 |
| Muller, CA | 1 |
| Kralios, AC | 1 |
| Picke, D | 1 |
| Liusov, VA | 1 |
| Volov, NA | 1 |
| Dibirova, GO | 1 |
| Uteshev, DB | 1 |
| Poliakova, ED | 1 |
| Ivanova, TN | 1 |
| Nikulina, SE | 1 |
| Metel'skaia, VA | 1 |
| Olfer'ev, AM | 1 |
| Shcherbakova, IA | 1 |
| Akhmedzhanov, NM | 1 |
| Perova, NV | 1 |
| Andrews, TC | 1 |
| Fenton, T | 2 |
| Toyosaki, N | 1 |
| Glasser, SP | 2 |
| Young, PM | 2 |
| MacCallum, G | 2 |
| Gibson, RS | 1 |
| Shook, TL | 2 |
| Stone, PH | 2 |
| Hoque, AN | 2 |
| Nasa, Y | 1 |
| Vatner, SF | 1 |
| Hittinger, L | 1 |
| Du, XJ | 1 |
| Riemersma, RA | 1 |
| Fox, KA | 1 |
| Dart, AM | 1 |
| Sobey, CG | 1 |
| Dalipram, RA | 1 |
| Woodman, OL | 1 |
| Iriarte, M | 1 |
| Molinero, E | 1 |
| Sagastagoitia, JD | 1 |
| Arzubiaga, J | 1 |
| Aguirre, J | 1 |
| Salcedo, A | 1 |
| Borzak, S | 1 |
| Simarro, E | 1 |
| Rodríguez, MA | 1 |
| Bayón, J | 1 |
| Lastra, JA | 1 |
| Prieto, P | 1 |
| Suárez, G | 1 |
| García Porrero, E | 1 |
| Fernández, R | 1 |
| Garrido, J | 1 |
| Velasco, J | 1 |
| Kono, M | 1 |
| Morita, S | 1 |
| Rubsamen, R | 1 |
| Adamson, PB | 1 |
| Hashizume, H | 2 |
| Hara, A | 2 |
| Iskenderov, BG | 1 |
| Tatarchenko, IP | 1 |
| Koley, J | 1 |
| Basak, AK | 1 |
| Das, M | 1 |
| Sinha, S | 1 |
| Koley, B | 1 |
| Magishi, K | 1 |
| Shehata, AR | 1 |
| Gillam, LD | 1 |
| Mascitelli, VA | 1 |
| Herman, SD | 1 |
| Ahlberg, AW | 1 |
| White, MP | 1 |
| Chen, C | 1 |
| Waters, DD | 1 |
| Heller, GV | 1 |
| Galenko-Iaroshevskiĭ, PA | 1 |
| Melkumova, ER | 1 |
| Bartashevich, VV | 1 |
| Uvarov, AV | 1 |
| Turovaia, AIu | 1 |
| Khankoeva, AI | 1 |
| Galygo, DS | 1 |
| Miura, H | 1 |
| Morgan, DA | 1 |
| Gutterman, DD | 1 |
| Shibasaki, K | 1 |
| Arai, Y | 1 |
| Uchida, W | 1 |
| Okazaki, T | 1 |
| Asano, M | 1 |
| Takenaka, T | 1 |
| Wijffels, MC | 1 |
| Kirchhof, CJ | 1 |
| Dorland, R | 1 |
| Power, J | 1 |
| Allessie, MA | 1 |
| Toleikis, PM | 1 |
| Tomlinson, CW | 1 |
| Senatorov, IuN | 1 |
| Mironova, NA | 1 |
| Kusuzaki, S | 1 |
| Yoshitake, M | 1 |
| Takigawa, O | 1 |
| Iwamoto, T | 1 |
| Zaslavskaia, RM | 1 |
| Goncharov, LF | 1 |
| Zholdin, BK | 1 |
| Bisengalieva, GK | 1 |
| Tanaka, H | 1 |
| Matsui, S | 1 |
| Shigenobu, K | 1 |
| Satoh, K | 1 |
| Yamamoto, A | 1 |
| Hoshi, K | 1 |
| Aupetit, JF | 1 |
| Frassati, D | 1 |
| Freysz, M | 1 |
| Faucon, G | 1 |
| Feuerstein, G | 1 |
| Liu, GL | 1 |
| Yue, TL | 1 |
| Cheng, HY | 1 |
| Hieble, JP | 1 |
| Arch, JR | 1 |
| Ruffolo, RR | 1 |
| Ma, XL | 1 |
| Houle, MS | 1 |
| Billman, GE | 1 |
| Campbell, CM | 1 |
| Wisenberg, G | 1 |
| Sykes, J | 1 |
| Thompson, RT | 1 |
| Egert, S | 1 |
| Nguyen, N | 1 |
| Schwaiger, M | 1 |
| Meyer, TE | 1 |
| Perlini, S | 1 |
| Foëx, P | 1 |
| Preedy, VR | 1 |
| Patel, VB | 1 |
| Reilly, ME | 1 |
| Richardson, PJ | 1 |
| Falkous, G | 1 |
| Mantle, D | 1 |
| Kurz, T | 1 |
| Schneider, I | 1 |
| Tölg, R | 1 |
| Richardt, G | 1 |
| Ohara, F | 1 |
| Sugimoto, T | 1 |
| Yamamoto, N | 1 |
| Ohkubo, K | 1 |
| Ozaki, T | 1 |
| Maeda, K | 1 |
| Seki, J | 1 |
| Goto, T | 1 |
| Morelli, S | 1 |
| Gurgo, AM | 1 |
| Martocchia, A | 1 |
| Falaschi, P | 1 |
| Guo, P | 1 |
| Pugsley, MK | 1 |
| Yong, SL | 1 |
| Walker, MJ | 1 |
| Mahmoudian, M | 1 |
| Shafiei, M | 1 |
| Mirkhani, H | 1 |
| Omrani, GR | 1 |
| Furukawa, Y | 1 |
| Chino, D | 1 |
| Yamada, C | 1 |
| Hashimoto, K | 1 |
| Hosoya, K | 1 |
| Takeda, K | 1 |
| Nishikimi, T | 1 |
| Ishimitsu, T | 1 |
| Matsuoka, H | 1 |
| Pantos, CI | 1 |
| Mourouzis, IS | 1 |
| Tzeis, SM | 1 |
| Asimacopoulos, P | 1 |
| Carageorgiou, HC | 1 |
| Varonos, DD | 1 |
| Cokkinos, DV | 1 |
| Blidaru, M | 1 |
| Cuparencu, B | 1 |
| Pleşca-Manea, L | 1 |
| Horio, T | 1 |
| Ito, S | 1 |
| Aoyama, M | 1 |
| Takeda, Y | 1 |
| Suzumura, H | 1 |
| Nakata, K | 1 |
| Yamada, Y | 1 |
| Suzuki, S | 1 |
| Fukutomi, T | 1 |
| Itoh, M | 1 |
| Carceles, MD | 1 |
| Aleixandre, F | 1 |
| Fuente, T | 1 |
| López-Vidal, J | 1 |
| Laorden, ML | 1 |
| Acanfora, D | 1 |
| Pinna, GD | 1 |
| Gheorghiade, M | 1 |
| Trojano, L | 1 |
| Furgi, G | 1 |
| Maestri, R | 1 |
| Picone, C | 1 |
| Iannuzzi, GL | 1 |
| Marciano, F | 1 |
| Takeichi, Y | 1 |
| Yokota, M | 1 |
| Iwase, M | 1 |
| Izawa, H | 1 |
| Nishizawa, T | 1 |
| Ishiki, R | 1 |
| Somura, F | 1 |
| Nagata, K | 1 |
| Isobe, S | 1 |
| Noda, A | 1 |
| Asahi, T | 1 |
| Shimabukuro, M | 1 |
| Oshiro, Y | 1 |
| Yoshida, H | 1 |
| Takasu, N | 1 |
| Dubova, TV | 1 |
| Iwai, T | 1 |
| Tanonaka, K | 1 |
| Kasahara, S | 1 |
| Inoue, R | 1 |
| Takeo, S | 1 |
| Becker, LC | 1 |
| Ferreira, R | 1 |
| Thomas, M | 1 |
| Kuzmin, AI | 1 |
| Tskitishvili, OV | 1 |
| Serebryakova, LI | 1 |
| Saprygina, TV | 1 |
| Kapelko, VI | 1 |
| Medvedev, OS | 1 |
| Vorob'ev, LP | 1 |
| Voronkov, LG | 1 |
| Lysenko, AF | 1 |
| Glezer, GA | 1 |
| Moskalenko, NP | 1 |
| Gaponenko, VA | 1 |
| Stoliarov, AS | 1 |
| Saitova, RA | 1 |
| Simbirina, TE | 1 |
| Neĭman, DIu | 1 |
| Chilikina, ON | 1 |
| Akhmetova, MG | 1 |
| Babaev, AB | 1 |
| Kogan, AK | 1 |
| Kudrin, AN | 1 |
| Losev, NI | 1 |
| Pristrom, MS | 1 |
| Mrochek, AG | 1 |
| Gorbachev, VV | 1 |
| Tiabut, TD | 1 |
| Sokolov, EI | 1 |
| Zaev, AP | 1 |
| Burmantova, NP | 1 |
| Khovanskaia, TP | 1 |
| Petrin, SV | 1 |
| Filonov, VK | 1 |
| Tebloev, KI | 1 |
| Pereponov, IuP | 1 |
| Hussain, ME | 1 |
| Krishana, B | 1 |
| Singh, M | 1 |
| Fahim, M | 1 |
5 reviews available for propranolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Nonselective beta-blocking agent improves the outcome of cardiopulmonary resuscitation in a rat model.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Dogs; Heart Arrest; Male; Mice; | 2004 |
Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.
Topics: Animals; Cardiomegaly; Coronary Circulation; Disease Models, Animal; Dogs; Heart; Hemodynamics; Myoc | 1993 |
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Dilazep; Diltiazem; Ene | 1996 |
Oxidants, antioxidants and alcohol: implications for skeletal and cardiac muscle.
Topics: Animals; Antioxidants; Cardiomyopathies; Ethanol; Humans; Muscle, Skeletal; Musculoskeletal Diseases | 1999 |
Thyrotoxicosis, unstable angina and normal coronary angiogram.
Topics: Angina, Unstable; Anti-Arrhythmia Agents; Chest Pain; Combined Modality Therapy; Coronary Angiograph | 1999 |
15 trials available for propranolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electr | 2002 |
[Status of microcirculation and cardiodynamics in ischemic heart disease patients with decreased left ventricular fraction and their response to carvedilol].
Topics: Carbazoles; Carvedilol; Cross-Over Studies; Heart; Humans; Microcirculation; Myocardial Ischemia; Pr | 2002 |
[Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Antioxida | 2003 |
Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Dipyridamole | 1995 |
[The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
Topics: Adult; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Exercise Tolerance; Humans; Ma | 1994 |
Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Electrocard | 1995 |
Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)
Topics: Circadian Rhythm; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rat | 1993 |
Usefulness of exercise testing performed with vasodilators for predicting the severity of myocardial ischaemia during daily activities and treatment.
Topics: Activities of Daily Living; Adult; Angina Pectoris; Coronary Circulation; Coronary Disease; Drug The | 1993 |
Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Topics: Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Tes | 1993 |
[The effect of gallopamil and propranolol in patients with ischemic cardiopathy and moderate depression of ventricular function].
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method | 1995 |
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Drug Therapy, Combination; Femal | 1996 |
Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography; Female; Heart; Hemodynamics; Humans; Male; M | 1997 |
Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; E | 2000 |
[Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
Topics: Carbazoles; Carvedilol; Cross-Over Studies; Hemodynamics; Humans; Myocardial Ischemia; Propanolamine | 2001 |
[Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
Topics: Angina Pectoris; Drug Therapy, Combination; Humans; Myocardial Ischemia; Nifedipine; Periodicity; Pr | 1992 |
104 other studies available for propranolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of Propranolol and Verapamil on Changes in TQ and ST Segment Potentials During Graded Coronary Flow Reduction in a Porcine Myocardial Ischemia Model.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Disease Models, Animal; Electrocardi | 2017 |
Ghrelin Preserves Ischemia-Induced Vasodilation of Male Rat Coronary Vessels Following β-Adrenergic Receptor Blockade.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Ghrelin; Heart Rate; Male; Myocardial Infarc | 2018 |
Myocardial hypersensitivity to ischemic injury is not reversed by clonidine or propranolol in a predator-based rat model of posttraumatic stress disorder.
Topics: Adrenergic Agents; Animals; Anxiety; Cardiovascular Agents; Clonidine; Disease Models, Animal; Disea | 2019 |
[Effect of propranolol on dialysate myoglobin levels evoked by ischemia/reperfusion].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dialysis Solutions; Heart R | 2013 |
[Pulmonary hemodynamics following experimental myocardial ischemia after the blockade of adrenergic receptors].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; | 2015 |
Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Heart Atria; Ischem | 2008 |
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cyclic AMP-Dep | 2009 |
Validation of 3-dimensional speckle tracking imaging to quantify regional myocardial deformation.
Topics: Animals; Dobutamine; Echocardiography; Endocardium; Exercise Test; Image Enhancement; Imaging, Three | 2009 |
Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Cyclic AMP; Cyclic AMP-Dependent Protein Ki | 2010 |
Restraint stress induces connexin-43 translocation via α-adrenoceptors in rat heart.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Connexin 4 | 2010 |
Does remodeling of gap junctions and connexin expression contribute to arrhythmogenesis? Study in an immobilization rat model.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Arrhythmia | 2010 |
Heart failure: acute ischemic events in HF--should we include sudden death?
Topics: Adrenergic beta-1 Receptor Antagonists; Antihypertensive Agents; Benzopyrans; Death, Sudden, Cardiac | 2011 |
Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Disease Model | 2011 |
Urgent implantable cardioverter defibrillator deactivation by unconventional means.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Device Removal; Female; Humans; Myocardia | 2011 |
[Ischemic heart disease in elderly patients of behavioral type A (psychosocial and clinic functional changes, possibilities for correction)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Anti-Anxiety Agents; Behavioral Symptoms; Benzodiaz | 2011 |
[The pulmonary hemodynamic changes under experimental myocardial ischemia in rabbits following beta-adrenoreceptors blockade].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Coronary Occlusion; Heart Vent | 2011 |
[Metabonomic phenotype of "formula corresponding to pattern types" based on "qi and yin deficiency pattern" of myocardial ischemia rat model].
Topics: Animals; Anti-Arrhythmia Agents; Drug Combinations; Drugs, Chinese Herbal; Endothelin-1; Gas Chromat | 2011 |
Cardioprotective effect of total paeony glycosides against isoprenaline-induced myocardial ischemia in rats.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Cardiotonic Agents; Creatine Kinase; Disease Mod | 2012 |
Role of variations in pulmonary and cardiac hemodynamics in the reduction of the venous return during experimental ischemia of the left ventricular myocardium.
Topics: Animals; Blood Pressure; Cats; Electric Stimulation; Heart; Heart Rate; Heart Ventricles; Lung; Myoc | 2012 |
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status.
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Disease Mode | 2013 |
Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Ant | 2002 |
Effect of adrenergic stimulation on Rb(+) uptake in normal and ischemic areas of isolated pig hearts: (87)Rb MRI study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dobutamine; Epinephrine; In Vitro Te | 2002 |
[Coronary Spasm after Administration of Propranolol during Dobutamine Stress Echocardiography].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Chest Pain; Dobutamine; Echocardiography; Elect | 2002 |
[Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model].
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Brain Death; Catecholamines; Catheterization; Cran | 2002 |
Protective effects of centrally acting sympathomodulatory drugs on myocardial ischemia induced by sympathetic overactivity in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Electrocar | 2003 |
Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment.
Topics: Animals; Cardiotonic Agents; Dobutamine; Heart; Heart Ventricles; In Vitro Techniques; Myocardial Is | 2003 |
[Morphofunctional aspects of cardioprotective effect of propranolol in modelling of chronic ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Chronic Disease; Disease Models, Animal; Microscopy, | 2002 |
[Significance of behavior peculiarities in the treatment of patients with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Behavior; Female; Humans; Male; Middle Aged; Myocardial Is | 2003 |
Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs.
Topics: Animals; Benzazepines; Blood Pressure; Female; Heart Rate; Ivabradine; Male; Myocardial Ischemia; Ph | 2003 |
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Topics: 5'-Nucleotidase; Adenosine; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Cells, Cul | 2004 |
[Psychosomatic aspects of therapy in patients with ischemic heart disease of behavioral type A].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Propranolol; Psychophysiologic | 2004 |
Strategy for identifying an efficient dosage of beta-blocker for elderly patients with myocardial ischemia and preserved left ventricular function.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Exercise Test; Heart Rate; Heart Ventricles; H | 2004 |
Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Chronic Disease; Contraindications; Heart Vent | 2004 |
A preliminary study on the cardioprotection of acupuncture pretreatment in rats with ischemia and reperfusion: involvement of cardiac beta-adrenoceptors.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Electroac | 2006 |
Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Carbazoles; Carvedilol; Fatty Acids; Iodobenz | 2006 |
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Benzylamines; Female; Guinea P | 2007 |
Spinal anesthesia attenuates myocardial ischemia during coronary artery spasm induced by intraaortic methacholine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Sp | 1995 |
Negative inotropic effect of propranolol is attenuated in underperfused feline heart with an acute ischemic region.
Topics: Animals; Blood Pressure; Cats; Coronary Circulation; Heart Rate; Injections, Intravenous; Male; Myoc | 1994 |
Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
Topics: Animals; Autonomic Nervous System; Cardiac Complexes, Premature; Cats; Electrocardiography; Flecaini | 1994 |
[The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
Topics: Adult; Aged; Analysis of Variance; Autonomic Nervous System; Cardiac Complexes, Premature; Drug Eval | 1994 |
[An observation on the pacemaker current I(f) in sheep cardiac Purkinje fibers under ischemia-mimic condition].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Ion Channels; Isoproterenol; Membrane | 1995 |
Preconditioning with dobutamine in the isolated rat heart.
Topics: Animals; Dobutamine; Drug Interactions; Heart; Heart Rate; Lactates; Lactic Acid; Male; Myocardial C | 1995 |
Myocardial bridging involving more than one site of the left anterior descending coronary artery: an uncommon cause of acute ischemic syndrome.
Topics: Cardiac Catheterization; Coronary Angiography; Coronary Vessel Anomalies; Diagnosis, Differential; E | 1995 |
Roles of alpha 1-adrenoceptor activity in the release of nitric oxide during ischemia of the canine heart.
Topics: Animals; Arginine; Dogs; Hemodynamics; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Este | 1995 |
Effects of bunazosin, a selective alpha 1-blocking agent, and propranolol used alone and in combination on canine ventricular refractoriness and its dispersion during myocardial ischemia.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Dogs; Drug Therapy, Combination; Electr | 1993 |
[The correction of the hemodynamic disorders in patients with IHD complicated by intraventricular blocks by using beta-adrenergic agents].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Bundle-Branch Block; Drug Evaluation; | 1995 |
Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion.
Topics: Adenosine; Animals; Cats; Coronary Circulation; Doxazosin; Heart; Hemodynamics; Male; Myocardial Con | 1995 |
Effects of sympathetic stimulation, with and without previous alpha 1 and beta adrenoceptor blockade, on refractoriness dispersion in canine heart.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Electrophysiology; Heart; Myocardial Ischemia; Proprano | 1994 |
Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Electric Stimulation; Fluorescence; Free | 1993 |
Alpha 1-adrenergic blockade and sudden cardiac death.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac | 1994 |
Effects of tilisolol on ischemic myocardial metabolism in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Carbohydrate Metabolism; Coronary Vess | 1994 |
Intracavitary filling pattern in the failing left ventricle assessed by color M-mode Doppler echocardiography.
Topics: Animals; Blood Flow Velocity; Cardiac Output, Low; Diastole; Dogs; Echocardiography, Doppler; Female | 1994 |
Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation.
Topics: Animals; Blood Pressure; Cardiopulmonary Resuscitation; Coronary Circulation; Dogs; Epinephrine; Myo | 1994 |
[Adverse effects in the microcirculatory bed during obsidan treatment of patients with ischemic heart disease and possibilities of their correction by trental].
Topics: Adult; Arterioles; Drug Therapy, Combination; Female; Forearm; Humans; Male; Microcirculation; Middl | 1993 |
Synergistic effects of haemodynamic stabilisation and beta blockade on ventricular fibrillation threshold in coronary artery ligated pigs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Myocardial Ische | 1993 |
Effects of propranolol, pindolol and carteolol on acute regional myocardial ischemia in isolated rabbit hearts.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Catecholamines; Coronary Circulation; Electric Stim | 1993 |
[The prognosis of drug therapy efficacy in ventricular rhythm disorders by the level of intracellular Ca2+ in the lymphocytes of patients with ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Drug Evaluation; Drug Therapy, Combinat | 1993 |
[Changes in the rate of cholesterol synthesis in lymphocytes, and blood lipid and lipoprotein levels in patients with ischemic heart disease and hypercholesterolemia during treatment with lovastatin and obsidan].
Topics: Adult; Cholesterol; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lipi | 1994 |
Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Fatty Acids, Nonesterified; Male; Myocardial | 1993 |
Propranolol and lidocaine inhibit neural norepinephrine release in hearts with increased extracellular potassium and ischemia.
Topics: Animals; Extracellular Space; Heart; Lidocaine; Male; Myocardial Ischemia; Norepinephrine; Perfusion | 1993 |
Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs.
Topics: Allopurinol; Amlodipine; Anesthetics; Animals; Dogs; Endothelium, Vascular; Female; Male; Myocardial | 1993 |
Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Fema | 1995 |
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Electrocardiography; Heart Rate; Myocardial I | 1995 |
[The characteristics of the effect of obzidan on the cardiac hemodynamics in patients with an artificial pacemaker when used one time and over a course of treatment].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Chronic Disease; Combined Modality Therapy; Female; Heart; | 1996 |
Rectal response of cardiac origin in the cat: involvement of nitric oxide and acetylcholine.
Topics: Acetylcholine; Afferent Pathways; Animals; Arginine; Atropine; Blood Pressure; Cats; Coronary Vessel | 1997 |
A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cats; Dilazep; Enzyme Activation; Heart; Humans; In V | 1997 |
[Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Histamine H1 Antagonists; Indoles; Myocardial Inf | 1996 |
Oxygen-derived free radicals contribute to neural stunning in the canine heart.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Catalase; Coronary Vessels; Dogs; Electric Stimulation | 1997 |
Antianginal effects of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models.
Topics: 4-Aminopyridine; Adrenergic beta-Antagonists; Amifampridine; Angina Pectoris; Animals; Calcium Chann | 1997 |
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Atrial Natriuretic Factor; At | 1997 |
Myocardial functional preservation during ischemia: influence of beta blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Heart; Heart Function Tests; Male; Myocardial Infarction; Myoc | 1997 |
[The dynamics of blood lipid composition in patients with ischemic heart disease in the process of multiple laser therapy combined with anaprilin and verapamil administration].
Topics: Cholesterol; Combined Modality Therapy; Humans; Infrared Rays; Laser Therapy; Male; Middle Aged; Myo | 1997 |
Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1997 |
[Betacap efficiency in elderly patients with coronary heart disease and essential hypertension].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiography, Impedance; Delayed-Action Preparations; E | 1998 |
Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem.
Topics: Animals; Diltiazem; Epoprostenol; Guinea Pigs; Heart; Myocardial Contraction; Myocardial Ischemia; M | 1998 |
Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs.
Topics: Animals; Atropine; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dogs; Femal | 1998 |
Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Cardiac Pacing | 1998 |
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Pressure; Ca | 1998 |
Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Arteries; Atropine; Constriction, Pathologic; Coronary Vessels | 1999 |
Noninvasive assessment of pharmaceutical intervention during myocardial ischemia-reperfusion in a canine model using two-dimensional 31P chemical shift imaging.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Circulat | 1998 |
Contribution of alpha-adrenergic and beta-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-A | 1999 |
Nonischemic end-systolic performance. Effect of alterations in regional and global left ventricular contractility.
Topics: Animals; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Infusions, Intra- | 1999 |
Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1998 |
Alpha 1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Analysis of | 1999 |
Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other cardioprotective compounds.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzyl Alcohol; Benzyl Alcohols; Diltiazem; Dose-Response | 1999 |
Cardiac transplantation does not effect ischaemia-induced arrhythmias in rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac | 1999 |
Effects of different vasodilators on human internal mammary artery in vitro.
Topics: Ethanolamines; Female; Humans; In Vitro Techniques; Isoproterenol; Isosorbide Dinitrate; Male; Mamma | 1999 |
Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Benzazepines; Blood Pressure; Cardiac Pa | 2000 |
Force-length relationship in dogs as a measure of protective effect of imidapril on regional myocardial ischemia and reperfusion injury.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atropine; Blood Pres | 2000 |
Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts.
Topics: Adrenergic beta-Antagonists; Animals; Glycogen; Hyperthyroidism; Hypertrophy, Left Ventricular; Male | 2000 |
The influence of intracerebroventricular administration of (+/-) propranolol and (+/-) verapamil on experimental myocardial ischemia and necrosis in rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Injections, Intr | 2000 |
Effect of carvedilol on atrioventricular conduction in the ischemic heart.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bundle of His | 2001 |
Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Ma | 2001 |
Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy.
Topics: Adult; Aged; Blood Pressure; Cardiomyopathy, Hypertrophic; Catecholamines; Diastole; Electrocardiogr | 2001 |
Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell S | 2001 |
Protective effect of propranolol on mitochondrial function in the ischaemic heart.
Topics: Adenosine Triphosphate; Animals; Calcium; Creatine Kinase; Cytochrome c Group; In Vitro Techniques; | 2002 |
Effect of propranolol and isoprenaline on regional left ventricular blood flow in experimental myocardial ischaemia.
Topics: Animals; Coronary Circulation; Dogs; Electrocardiography; Heart Ventricles; Isoproterenol; Microsphe | 1975 |
Cardiac microdialysis measurement of extracellular adenine nucleotide breakdown products during regional ischemia and reperfusion in canine heart: protective effect of propranolol against reperfusion injury.
Topics: Adenine Nucleotides; Animals; Chromatography, High Pressure Liquid; Dialysis; Dogs; Energy Metabolis | 1992 |
[The effect of nitrosorbide, korinfar, obzidan and spesikor on cardiovascular function in a right bundle of His block].
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiovascular System; Drug Evaluation; Electroc | 1992 |
[ Combined therapy with isosorbide dinitrate, propranolol and nifedipine in patients with chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Drug Therapy, Combination; Heart Rate; Hemodynamics; | 1992 |
The mechanisms of free-radical lipids and antioxidant heart protection in experimental ischaemia and infarction.
Topics: Animals; Female; Free Radicals; Lipid Peroxidation; Male; Malondialdehyde; Microscopy, Electron; Myo | 1992 |
[A comparative evaluation of the effect of anaprilin and teonikol on thrombocyte aggregation indices in patients with ischemic heart disease from older age groups].
Topics: Adrenal Cortex Hormones; Aged; Aging; Drug Evaluation; Female; Humans; Male; Middle Aged; Myocardial | 1992 |
[The effect of anaprilin on the reaction of the sympathetic-adrenal system to graded physical loading in healthy subjects and patients with ischemic heart disease].
Topics: Adrenal Glands; Adult; Angina Pectoris; Catecholamines; Exercise Test; Humans; Male; Middle Aged; My | 1992 |
Inhibition of arterial baroreceptor reflex during coronary artery occlusion.
Topics: Animals; Atropine; Blood Pressure; Dogs; Female; Heart Rate; Male; Myocardial Ischemia; Pressorecept | 1992 |